Weaver C. Barksdale & Associates, Inc. - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
Weaver C. Barksdale & Associates, Inc. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$5,000
-16.7%
30
-45.5%
0.00%
-20.0%
Q4 2014$6,000
-99.8%
55
-99.7%
0.01%
-99.8%
Q3 2014$2,615,000
+7.9%
16,736
-14.8%
2.16%
+10.6%
Q2 2014$2,423,000
+60475.0%
19,646
+54472.2%
1.95%
+64833.3%
Q1 2014$4,0000.0%36
-26.5%
0.00%0.0%
Q4 2013$4,000
+33.3%
490.0%0.00%0.0%
Q3 2013$3,000490.00%
Other shareholders

There were no reported owners of SALIX PHARMACEUTICALS INC in Q3 2014.

NameSharesValueWeighting ↓
View complete list of SALIX PHARMACEUTICALS INC shareholders